Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending June 11, 2017
Monocytosis Prevalence in PV Evaluated, Am J Hematol; ePub 2017 May 26; Barraco, et al
These MPNs Are More Likely to Progress to Leukemia, Future Oncol; ePub 2017 Jun 7; Shrestha, et al
TIPS for Resolving Portal Hypertension in MPN Patients, Am J Hematol; ePub 2017 May 24; Reilly, et al
Outcomes After UCBT in MDS Patients Evaluated, Biol Blood Marrow Transplant; 2017 Jun; Gerds, et al
IGHV Mutational Status Testing in Patients with CLL, Am J Hematol; ePub 2017 Jun 7; Crombie, et al
Must reads for theWeek ending May 28, 2017
Practical Measures of Ruxolitinib’s Clinical Benefit, Clin Lymphoma Myeloma Leuk; ePub 2017 May 12; Miller, et al
Fewer Thromboembolic Events with Ruxolitinib?, Br J Haematol; ePub 2017 May 17; Harrison, et al
JAK Inhibitors’ Role in Symptom Relief Reviewed, Biol Blood Marrow Transplant; ePub 2017 May 9; Jain, et al
Ruxolitinib’s for MF and Potential in ET Reviewed, Blood; ePub 2017 May 12; Bose, Verstovsek
Cost of Antithrombin Therapy in Hematologic Malignancies, Leuk Lymphoma; ePub 2017 May 9; Barreto, et al
Must reads for theWeek ending May 14, 2017
Adding Ruxolitinib to Certain Patients with T-ALL, Leukemia; ePub 2017 May 9; Delgado-Martin, et al
Which Liver Function Test Has Prognostic Relevance? , Blood Cancer J; ePub 2017 Apr 21; Barraco, et al
Grouping Patients with PV by Cytogenic Abnormalities, Haematologica; ePub 2017 May 24; Tang, et al
Risk Categories for Patients with Atypical CML Evaluated, Am J Hematol; 2017 Jun; Patnaik, Barraco, et al
Ruxolitinib’s Impact on JAK2 Allele Burden in PV, Ann Hematol; ePub 2017 Apr 30; Vannucchi, et al
Must reads for theWeek ending April 23, 2017
Comparing MPN Mutational Profiles, Am J Clin Pathol; ePub 2017 Apr 15; Song, et al
Consider High-Intensity Chemo + TKI in These Patients, Am J Hematol; ePub 2017 Apr 6; Salem, et al
This Gene Alteration Is Linked with Poor Prognosis, Mod Pathol; ePub 2017 Mar 24; Hu, Medeiros, et al
Clinical Features of Genetic Aberrations Evaluated , Am J Hematol; ePub 2017 Mar 23; Kandarpa, et al
Managing Myelofibrosis: JAK Inhibition and Beyond, Expert Rev Hematol; ePub 2017 Apr 11; Stahl, et al
Must reads for theWeek ending April 9, 2017
Monocytosis Prevalence in Polycythemia Vera Evaluated , Am J Hematol; ePub 2017 Mar 28; Barraco, et al
Ruxolitinib as a Steroid-Sparing Agent for cGVHD , Biol Blood Marrow Transplant; 2017 Mar; Khoury, et al
Ruxolitinib in Children with Steroid-Refractory GVHD , Biol Blood Marrow Transplant; ePub 2017 Mar 23; Khandelwal, et al
The Clinical Significance of Low Haptoglobin in MF, Leuk Res; 2017 Mar 8; Strati, Masarova, et al
Combo Therapies Involving JAK-Inhibitors Reviewed, Curr Opin Hematol; 2017 Mar; Assi, et al